Warrenville, Illinois Clinical Trials

A listing of Warrenville, Illinois clinical trials actively recruiting patient volunteers.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 102 clinical trials
Combination Chemotherapy With or Without Atezolizumab in Treating Patients With Stage III Colon Cancer and Deficient DNA Mismatch Repair

This phase III trial studies combination chemotherapy and atezolizumab to see how well it works compared with combination chemotherapy alone in treating patients with stage III colon cancer and deficient deoxyribonucleic acid (DNA) mismatch repair. Drugs used in combination chemotherapy, such as oxaliplatin, leucovorin calcium, and fluorouracil, work in different …

hiv viral load
hysterectomy
metastasis
investigational agent
leucovorin
Northwestern Medicine Cancer Center Warrenville
 (1.4 away) Contact site
  • 1047 views
  • 26 Sep, 2021
  • +595 other locations
Observation or Radiation Therapy in Treating Patients With Newly Diagnosed Grade II Meningioma That Has Been Completely Removed by Surgery

This randomized phase III trial studies how well radiation therapy works compared with observation in treating patients with newly diagnosed grade II meningioma that has been completely removed by surgery. Radiation therapy uses high energy x-rays to kill tumor cells and shrink tumors.

central pathology review
step 2
x-rays
tumor cells
intracranial meningioma
Northwestern Medicine Cancer Center Delnor
 (7.3 away) Contact site
  • 835 views
  • 22 Sep, 2021
  • +194 other locations
Active Reference (Fluoxetine) Fixed-dose Study of Vortioxetine in Paediatric Patients Aged 7 to 11 Years With Major Depressive Disorder (MDD)

Investigation of the efficacy and safety of a new potential treatment of Major depressive disorder (MDD) in paediatric patients (age 7 to 11 years)

major depressive disorder
fluoxetine
vortioxetine
AMR Conventions Research
 (2.9 away) Contact site
  • 2 views
  • 26 Sep, 2021
  • +280 other locations
Pivotal Open-label Randomized Study of Radiosurgery With or Without Tumor Treating Fields (TTFields) for 1-10 Brain Metastases From Non-small Cell Lung Cancer (NSCLC).

The study is a prospective, randomized controlled phase III trial, to test the efficacy, safety and neurocognitive outcomes of advanced NSCLC patients, following stereotactic radiosurgery (SRS) for 1-10 brain metastases, treated with NovoTTF-100M compared to supportive treatment alone. The device is an experimental, portable, battery operated device for chronic administration …

Loyola University Medical Center
 (18.2 away) Contact site
  • 0 views
  • 25 Sep, 2021
  • +131 other locations
Study to Evaluate the Efficacy and Safety of 3 Fixed Doses of Intranasal Esketamine in Addition to Comprehensive Standard of Care for the Rapid Reduction of the Symptoms of Major Depressive Disorder Including Suicidal Ideation in Pediatric Participants Assessed to be at Imminent Risk for Suicide

The purpose of this study is to assess the efficacy of a single (first) dose of 3 fixed doses of intranasal esketamine {28 milligram (mg), 56 mg, and 84 mg} compared with psychoactive placebo (oral midazolam) in rapidly reducing the symptoms of major depressive disorder (MDD) including suicidal ideation in …

citalopram
depression
suicidal
major depressive disorder
psychiatric disorder
Neuroscience Research Institute
 (3.8 away) Contact site
  • 1845 views
  • 26 Sep, 2021
  • +90 other locations
A Study of Enfortumab Vedotin Alone or With Other Therapies for Treatment of Urothelial Cancer

This study will test an experimental drug (enfortumab vedotin) alone and with different combinations of anticancer therapies. Pembrolizumab is an immune checkpoint inhibitor (CPI) that is used to treat patients with cancer of the urinary system (urothelial cancer). This type of cancer includes cancer of the bladder, renal pelvis, ureter …

chemoradiation
hearing loss
combinations
glomerular filtration rate
metastasis
Northwestern Medicine Cancer Center - Warrenville / Central DuPage Hospital - Cancer Care
 (1.4 away) Contact site
  • 284 views
  • 24 Sep, 2021
  • +93 other locations
EARLY TAVR: Evaluation of TAVR Compared to Surveillance for Patients With Asymptomatic Severe Aortic Stenosis

This study will evaluate the safety and effectiveness of the Edwards SAPIEN 3/SAPIEN 3 Ultra Transcatheter Heart Valve (THV) compared with clinical surveillance (CS) in asymptomatic patients with severe, calcific aortic stenosis.

stenosis
aortic valve replacement
transcatheter aortic valve implantation
ejection fraction
Alexian Brothers Hospital Network
 (6.1 away) Contact site
  • 464 views
  • 16 Sep, 2021
  • +86 other locations
Testing the Addition of an Antibody to Standard Chemoradiation Followed by the Antibody for One Year to Standard Chemoradiation Followed by One Year of the Antibody in Patients With Unresectable Stage III Non-Small Cell Lung Cancer

This phase III trial studies how well an antibody (durvalumab) with chemotherapy and radiation therapy (chemoradiation) works in treating patients with stage III non-small cell lung cancer that cannot be removed by surgery (unresectable). Immunotherapy with monoclonal antibodies, such as durvalumab, may help the body's immune system attack the cancer, …

paclitaxel
hysterectomy
gilbert's syndrome
mitomycin
neutrophil count
Rush - Copley Medical Center
 (5.1 away) Contact site
  • 141 views
  • 26 Sep, 2021
  • +590 other locations
Anticoagulation in ICH Survivors for Stroke Prevention and Recovery

Primary Aim: To determine if apixaban is superior to aspirin for prevention of the composite outcome of any stroke (hemorrhagic or ischemic) or death from any cause in patients with recent ICH and atrial fibrillation (AF). Secondary Aim: To determine if apixaban, compared with aspirin, results in better functional outcomes …

aspirin
electrocardiogram
intracerebral hemorrhage
anticoagulation therapy
antiplatelet agents
Central DuPage Hospital
 (3.5 away) Contact site
  • 84 views
  • 26 Sep, 2021
  • +108 other locations
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer ALCHEMIST Chemo-IO Study

This phase III ALCHEMIST trial compares the addition of pembrolizumab to usual chemotherapy versus usual chemotherapy for the treatment of stage IIA, IIB IIIA or IIIB non-small cell lung cancer that has been removed by surgery. Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack …

platelet count
paclitaxel
carboplatin
pembrolizumab
neutrophil count
Rush - Copley Medical Center
 (5.1 away) Contact site
  • 136 views
  • 26 Sep, 2021
  • +813 other locations